Clydebank Patient Becomes First in the World to Take Part in Cardiac Gene Therapy Trial
The PROTECT trial uses gene therapy during bypass surgery to reduce vein graft failure and improve long-term patient outcomes, led by NHS Greater Glasgow and Clyde.
4 Articles
4 Articles
Cardiac gene therapy trial treats first patient | News | The University of Edinburgh
Cardiac gene therapy trial treats first patient jconway3 Wed, 07/01/2026 - 15:07 A Scottish patient has become the first person in the world to receive a pioneering therapy aimed at improving outcomes for those having specialist heart surgery. The treatment involves precisely editing DNA in veins to be used during heart bypass surgery to boost the production of a protective protein.The treatment could help extend the lifespan of blood vessels u…
Scottish patient becomes first to take part in groundbreaking cardiac gene therapy trial
A Scottish patient has become the first person in the world to undergo a clinical trial that aims to improve outcomes for those having specialist heart surgery. John MacDonald, 73, volunteered to take part in the new study, led by NHS Greater Glasgow and Clyde and the University of Glasgow, which uses gene therapy during… Continue reading >Scottish patient becomes first to take part in groundbreaking cardiac gene therapy trial The post Scotti…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

